Inhibin bB (INHBB; coding for the activin bB subunit) has previously been identified in both human and rodent adipose tissue and using Taqman real-time PCR with specific primers we confirm the expression of INHBB mRNA in rodent adipose tissue. Expression of INHBB in murine epididymal adipose tissue was higher than in any of the other tissues studied and appears to be regulated by changes in energy balance and leptin. It was increased fourfold in the epididymal fat depot of ob/ob mice compared with the same fat depot in lean mice. The i.p. administration of leptin in obese ob/ob mice decreases the expression of INHBB. In human adipose tissue, INHBB is reduced by weight loss. In keeping with this, we demonstrate that INHBB expression in murine adipose tissue is decreased in fasting and increased upon refeeding. We show that INHBB is expressed in both the mature adipocyte and the stromal vascular fraction of adipose tissue. INHBB increases with the differentiation of pre-adipocytes into mature adipocytes in the 3T3-L1 cell line. In differentiated 3T3-L1 adipocytes, where receptors to activin have been previously reported, insulin increases the expression of INHBB, while dexamethasone decreases the expression of INHBB when compared with untreated control cells. Taken together, these results suggest that the regulation of INHBB expression in adipose tissue may play a physiological role in energy balance or the insulin insensitivity associated with obesity.
Introduction
Activins are multifunctional growth factors that are functionally and structurally distinct members of the transforming growth factor (TGF)-b superfamily of proteins (Chang et al. 2002) . Although the majority of studies have focused on activin's role in reproduction and development, it is clear that activins also have a role locally in the cellular development and growth of different tissues (Muttukrishna et al. 2004 , Rodgarkia-Dara et al. 2006 , Werner & Alzheimer 2006 , Maeshima et al. 2008 . Activins are synthesised as homo-or heterodimers of two highly related disulphide-linked inhibin b subunits (inhibin bA (INBBA) and inhibin bB (INHBB)), which can result in three molecular species activin A, activin AB and activin B (Rodgarkia-Dara et al. 2006) . Thus, the INHBB subunit can form activin B together with another bB subunit (bB-bB) or activin AB together with the bA subunit (bA-bB). Two other subunits BC and BE are also members of the activin subgroup but research has focused more on the widely expressed bA and bB subunits (Rodgarkia-Dara et al. 2006) . These TGF-b families of proteins, acting as paracrine, autocrine or endocrine factors, have a wide range of functions essential in normal physiological and developmental processes.
Recently, INHBB was identified in human white adipose tissue, while INBBA, INBBC and INBBE were expressed at very low levels suggesting that INHBB is the predominant activin in human adipose tissue (Sjoholm et al. 2006) . Thus, these data suggest that only the activin B dimer is produced in human adipose tissue as the dimerisation of activin subunits occurs within the cell. This is in contrast to rodent adipose tissue, where both INHBA and INHBB mRNAs are expressed indicating a difference between the species (Vejda et al. 2002) . Type I and Type II receptors to activin are also expressed in human and rodent adipose tissue suggesting a possible autocrine or paracrine effect of activin (Rodgarkia-Dara et al. 2006 , Sjoholm et al. 2006 . Activin B has been shown to signal via an additional Type 1 receptor ALK7 when compared with activin A, which suggests that these activins may have different functions (Thompson et al. 2004 , Rodgarkia-Dara et al. 2006 ). Furthermore, the ALK7 receptor is highly expressed in human adipose tissue suggesting that activin B may have local effects in the adipose tissue (Carlsson et al. 2009 ).
INHBB coding for the activin bB is highly expressed in human adipocytes and the expression is decreased with diet-induced weight loss, correlating with serum levels of fasting insulin (Sjoholm et al. 2006 , Carlsson et al. 2009 ). To investigate the significance of this, we further investigated the changes in INHBB expression in diabetic obese ob/ob mice, 24 h fasted C57BL6 mice and in the 3T3-L1 adipocyte cell line.
Methods

Animals
Wild-type and obese ob/ob male mice on the C57BL6 background (all w11 weeks old) were purchased from Harlan UK Ltd (Bicester, Oxon, UK). Animals were maintained on a 12:12-h photoperiod with lights on at 0800 h. Room temperature was controlled at 20 8C (G1 8C) and humidity was regulated to be !70%. Food (Biosure CRM pelleted chow: Special Diets Services, Witham, Essex, UK) and water were available ad libitum unless stated. The CRM pelleted chow has an estimated metabolisable energy of 12-13 MJ/kg, partitioned as Atwater fuel energy, protein 22%, fat 9% and carbohydrate 69%.
All procedures were licensed under the UK Animals (Scientific Procedures) Act of 1986 and received ethical approval from the University of Aberdeen Rowett Institute of Nutrition and Health Ethical Review Committee.
I.p. leptin administration
A total of 10 obese (ob/ob) mice were used to determine the effect of the i.p. administration of leptin on the expression of INHBB in adipose tissue. Half the mice (nZ5), with ad libitum access to food and water, were injected i.p. with leptin (2 mg/kg body weight in saline) in the middle of the light phase. The other half (nZ5) received saline (100 ml) only. After 4 h, the mice were killed by cervical dislocation and tissues collected for analysis. All murine tissues described were carefully dissected and then frozen immediately in liquid nitrogen and stored at K80 8C until extraction of RNA.
Fasting
Food was withdrawn for 24 h from randomly selected lean C57BL6 mice soon after the onset of the light cycle, whereas control animals were provided with ad libitum access to chow. Some individuals from the fasted group were then permitted a 12 h ad libitum refeeding period. Animals were killed after 24 h (control and fasted groups) or 36 h (refed group; nZ8 per group). The adipose tissue was carefully dissected and then frozen immediately in liquid nitrogen and stored at K80 8C until extraction of RNA.
Mature adipocyte isolation
Mature adipocytes were isolated from the murine epididymal fat depot of 11 weeks old C57BL6 male mice. In brief, following dissection, the WAT samples were placed in 1% Albumin buffer (1% BSA in HEPES buffer). Following removal of blood vessels, the tissue was diced and transferred to collagenase buffer (1 mg/ml collagenase type II in HEPES buffer, pH 7 . 4) and placed in a shaking incubator at 37 8C for 1 h, or until digestion was complete. The digested tissue was passed through a 250 mm mesh and centrifuged at 200 g for 10 min to pellet the stromal vascular fraction (SVF). The mature fat cells floating at the top were then transferred to fresh tubes and rinsed thrice with HEPES buffer and centrifuged at 200 g for 5 min. Finally, excess buffer was removed and Tri-pure isolation reagent (Roche Diagnostics Ltd) was added. The stromal vascular pellet was incubated for 10 min in erythrocyte lysis buffer (154 mM NH 4 Cl, 5 . 7 mM K 2 HPO 4 and 0 . 1 mM EDTA, pH 7 . 3). The suspension was then centrifuged at 200 g for 10 min and the pellet was resuspended in Tri-pure isolation reagent (Roche Diagnostics Ltd).
3T3-L1 cell culture
3T3-L1 cells were obtained from the LGC Promochem (Teddington, Middlesex, UK) and cultured at 37 8C in a humidified atmosphere of 5% CO 2 and 95% air. The cells were maintained in a culture medium containing the following: DMEM (Invitrogen) with 25 mM glucose, 1 mM pyruvate, 4 . 02 mM L-alanyl-L-glutamine and 10% FCS (Sigma). Differentiation was initiated 24 h after confluence by incubation for 2 days in a culture medium containing 0 . 25 mM dexamethasone (Dex), 0 . 5 mM 3-isobutyl-1-methyl-xanthine and 5 mg/ml insulin (Sigma). This was followed by maintenance in feeding medium (renewed every 2/3 days) consisting of culture medium containing 5 mg/ml insulin. Cells were fully differentiated by day 11 with over 90% of the cells containing lipid droplets. The cells were maintained for up to 11 days after the induction of differentiation and sampled every 2-3 days. In some experiments, fully differentiated adipocytes at day 11 were incubated for a further 24 h with insulin (1 and 10 mM), leptin (10, 100 and 1000 nM), lipopolysaccharide (LPS; 25 and 75 ng/ml) or Dex (2 and 20 nM). All reagents were purchased from Sigma. Cells were harvested and RNA was extracted as described below for PCR analysis.
Real-time quantitative PCR (Taqman system) RNA was extracted using the Tri-pure isolation reagent, for DNA-free RNA, following the manufacturer's instructions (Roche Diagnostics Ltd). RNA was accurately quantified on the Agilent 2100 Bioanalyser (Agilent Technologies, South Queensferry, West Lothian, UK). This also shows the quality of the RNA extracted from the tissues. Only RNA showing no degradation was processed further. Reverse transcription was carried out on 3-5 mg of RNA using the Superscript first strand synthesis system (Invitrogen Cat No: 12371-019) according to the manufacturer's instructions. The cDNA was amplified by PCR using rodent-specific (Applied Biosystems cat number Mm 01286587_m1) primers for the INHBB gene or for the leptin gene (Applied Biosystems, Warrington, Cheshire, UK, cat number Mm00434759_m1).
PCR was performed on an Applied Biosystems ABI Prism 7700 sequence detection system (Perkin-Elmer Applied Biosystems, Inc., Foster City, CA, USA). Commercial reagents (TaqMan PCR Reagent Kit, Perkin-Elmer) and conditions were employed according to the manufacturer's protocol. cDNA (1 ml; reverse transcription mixture) and oligonucleotides with a final concentration of 300 nmol/l primers and 200 nmol/l TaqMan hybridisation probe were added to 10 ml reaction mix.
PCR was performed under the following conditions: step 1, 95 8C (20 s) for 1 cycle; step 2, 95 8C (3 s); 60 8C (30 s) for 40 cycles. All samples were run in triplicate and were all within the standard curve.
A serial dilution of known copy numbers of a PCR product served as reference (standard curve) providing a relative quantification of the unknown samples. Target gene expression was related to the housekeeping genes b-actin (Primers obtained from Applied Biosystems cat number rodent Mm00607939_s1) and b-2microglobulin (B2M; Primers obtained from Applied Biosystems cat number rodent Mm00437762_s1), following the manufacturer's instructions. All of the primers and probes were purchased from Applied Biosystems as TaqMan Gene Expression Assays, which have been designed and validated by Applied Biosystems. Further details of all the primers are available at the Applied Biosystems website under the catalogue numbers provided.
Values were standardised to b-actin and expressed as a percentage of the control. Similar data were obtained when the values were standardised to B2M (data not shown). Suitable controls were carried out to eliminate any potential for spurious amplification from contaminating genomic DNA.
Statistical analysis
Comparisons between groups were made using unpaired Student's t-tests. Results were considered statistically significant if the P%0 . 05. Where appropriate the data were also analysed by one-or two-way ANOVA using GenStat version 11.
Results
Expression of INHBB mRNA in murine tissues
To determine the level of expression of INHBB mRNA in murine tissues we carried out real-time PCR with the Taqman system on a range of tissues dissected from lean C57BL6 mice that had ad libitum access to food and water. We also compared the expression in the murine subcutaneous, epididymal and perirenal adipose tissue depots (Fig. 1) .
INHBB expression in murine epididymal adipose tissue was at least twofold higher than the other tissues studied including perirenal and subcutaneous adipose tissue, spleen, Bat (brown adipose tissue), kidney, liver, heart, testis and lung (P%0 . 01). Excluding the epididymal adipose tissue, INHBB was expressed at higher levels in the testis of these mice compared with other tissues (P%0 . 05) in keeping with previous reports (Vejda et al. 2002) . Owing to the high level of INHBB mRNA expression in the murine epididymal adipose tissue, data are presented mainly for this fat depot in subsequent experiments.
Expression of INHBB mRNA in the adipose tissue of obese ob/ob compared with C57BL6 lean mice: effect of i.p. administration of leptin to obese ob/ob mice compared with saline-treated controls
To determine whether INHBB mRNA in adipose tissue is regulated by changes in leptin, we carried out realtime PCR in the obese diabetic ob/ob mouse using the Taqman assay with primers specific to INHBB (Fig. 2) . To determine whether adipose tissue INHBB mRNA is altered by changes in the feeding status, we fasted C57BL6 lean mice for 24 h. Some individuals from the fasted group were then permitted a 12 h ad libitum refeeding period. We measured INHBB mRNA by the Taqman assay in epididymal adipose tissue (Fig. 3) . INHBB mRNA is decreased in the fasted C57BL6 lean mice relative to the fed controls (P%0 . 01). INHBB mRNA increased in fasted C57BL6 lean mice that were subsequently refed for a further 12 h (P%0 . 01). Using one-way ANOVA, there is a significant effect of fasting on INHBB gene expression (PZ0 . 027).
INHBB mRNA is expressed in mature adipocytes and the SVF
Adipose tissue is heterogeneous at the cellular level with mature adipocytes comprising no more than 50% of the total cell content. To establish the cellular localisation of INHBB in WAT, epididymal fat from C57BL6 mice was fractionated by collagenase digestion into stromal vascular and mature adipocyte components. INHBB mRNA was measured using the Taqman assay and products for INHBB mRNA were observed in both the adipocyte and SVFs (Fig. 4) . As expected, leptin mRNA expression was mainly expressed in the mature adipocyte fraction.
INHBB mRNA is expressed in the murine adipocyte 3T3-L1 cell line
The developmental expression of INHBB mRNA during the course of differentiation from pre-adipocytes into mature adipocytes was determined using the Taqman assay in the 3T3-L1 adipocyte cell line (Fig. 5) .
INHBB mRNA can be readily detected in preadipocytes and differentiated mature adipocytes. INHBB mRNA remained unchanged during the first 2 days of culture in medium containing 0 . 25 mM Dex, 0 . 5 mM 3-isobutyl-1-methyl-xanthine and 5 mg/ml insulin. Thereafter, INHBB mRNA levels gradually increased with increasing differentiation of the preadipocytes into mature adipocytes (P%0 . 001). As expected, leptin mRNA levels also increased with increasing differentiation of the pre-adipocytes into mature adipocytes as previously reported (Rentsch & Chiesi 1996) . Differentiation of the 3T3-L1 cells from pre-adipocytes into mature adipocytes was also evident from the accumulation of intracellular lipid droplets for which the differentiation rate was O90%.
Regulation of INHBB mRNA expression in differentiated murine adipocyte 3T3-L1 cells
To investigate the regulation of INHBB gene expression in vitro, we incubated differentiated day 11 murine adipocyte 3T3-L1 cells with insulin (1 or 10 mM), leptin (10, 100 or 1000 nM), LPS (25 or 75 ng/ml) or Dex (2 or 20 nM) for 24 h and compared with control untreated cells (Fig. 6 ).
Insulin (1 and 10 mM) increased INHBB mRNA expression by w50% (P%0 . 01) when compared with the untreated control differentiated murine adipocytes. INHBB mRNA expression was decreased by w25% with LPS (25 and 75 ng/ml; P%0 . 01) and w70% with Dex (2 and 20 nM; P%0 . 001; Fig. 6 ). The addition of leptin (10, 100 or 1000 nM) had no effect on INHBB mRNA expression measured using the Taqman assay (Fig. 6 ). This is in contrast to the in vivo studies showing a decrease in INHBB mRNA in adipose tissue in response to i.p. administration of leptin to obese C57BL6 mice (Fig. 2) . It is also in contrast to the decrease of INHBB we observed in fasting (Fig. 3) which would also decrease leptin levels, suggesting that leptin has an indirect effect on INHBB mRNA expression (Ueno et al. 2007 ). Using one-way ANOVA, there is a significant effect of treatment on INHBB gene expression (P!0 . 001).
Discussion
A previous study by Sjoholm et al. (2006) can form activin B/AB protein derived from adipose tissue, may be regulated by insulin or could regulate insulin secretion from the pancreatic islets. To begin to address this hypothesis, we investigated the expression of INHBB mRNA from adipose tissue in ob/ob mice, fasted mice and in differentiated 3T3-L1 cells.
We show in this study that INHBB mRNA in C57BL6 mice is expressed at a high level in the epididymal adipose tissue depot compared with the perirenal and subcutaneous adipose tissue depot as well as a range of other tissues including the testis, a tissue where high expression has previously been reported (Vejda et al. 2002) . Real-time PCR analysis, of two adipose tissue depots, demonstrates that INHBB is increased in the adipose tissue of obese diabetic ob/ob mice compared with lean mice on the same C57BL6 background. Leptin administration to rodents is known to improve insulin sensitivity by reducing intracellular lipid levels in skeletal muscle, liver and pancreatic b-cells (Minokoshi et al. 2002) . The administration of leptin peripherally to the obese (leptin-deficient) ob/ob mouse in this study caused a decrease in INHBB mRNA expression in the adipose tissue. This association between leptin levels and expression of INHBB mRNA in adipose tissue in vivo contrasts with our in vitro findings, which show no effect of leptin on INHBB mRNA in differentiated 3T3-L1 adipocytes. This suggests that the effect of leptin on the adipose tissue expression of INHBB in vivo occurs indirectly.
It may be the increase in plasma insulin associated with obesity in diabetic ob/ob mice compared with lean mice causes the increase in INHBB mRNA that we observe in the adipose tissue depots of these mice (Kulkarni et al. 1997) . In keeping with this, we show that insulin increases INHBB expression in differentiated 3T3-L1 adipocytes. Additionally, if the increase in INHBB mRNA in the adipose tissue reflects an increase in plasma activins, this may be partly responsible for the observed increase in plasma insulin in obese ob/ob mice compared with lean mice. Previous studies have shown that activins composed of the INHBB subunit cause an increase in insulin with specific activin receptors being present on pancreatic islet cells (Tsuchida et al. 2004 ). It should be noted that follistatin and other carrier proteins are known to bind activin in the blood abolishing receptor binding and thus limiting the bioavailability of activin. However, the affinity of follistatin for activin B composed of INHBB subunits is reported to be w10-fold lower than that for activin A (Rodgarkia-Dara et al. 2006) . Similarly, the administration of leptin to ob/ob mice may indirectly, through changes in plasma insulin, cause the observed decrease in the expression of INHBB mRNA in adipose tissue (Kulkarni et al. 1997) . By reducing the insulin stimulus, we would expect the levels of INHBB in the adipose tissue to decrease, given that we show insulin increases whereas by contrast, mice homozygous for the inhibanull allele are viable, fertile and have eye defects. Interestingly, replacement of the inhiba-null alleles by the inhibb allele has been shown to give rise to cachexia in these recombinant mice and also effects adipose tissue mass (Brown et al. 2000) . This paper also provides support for a role of INHBB in relation to food intake, in that INHBB mRNA expression increases with obesity in the ob/ob mouse and decreases with fasting. Additional studies are needed to clarify the effects of obesity and type 2 diabetes on INHBB expression.
In conclusion, INHBB is expressed in mature adipocytes and in adipocytes differentiated in primary culture, as well as in the SVF of adipose tissue. We show that the expression of INHBB in murine adipose tissue is regulated by changes in obesity and feeding status. We further show that INHBB is regulated by leptin in vivo, and by insulin, LPS and Dex but not leptin in vitro, in differentiated mature 3T3-L1 adipocytes. Taken together, these results suggest that the regulation of INHBB expression in adipose tissue may play a physiological role in the energy balance or the insulin insensitivity associated with obesity.
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